Trials / Completed
CompletedNCT00672074
Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus
A Phase II, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety and Efficacy of Ipamorelin Compared to Placebo for the Management of Post-Operative Ileus in Patients
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 117 (actual)
- Sponsor
- Helsinn Therapeutics (U.S.), Inc · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if ipamorelin is safe and effective in the management of post-operative ileus.
Detailed description
The safety and efficacy of ipamorelin in the management of post-operative ileus
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ipamorelin | IV |
| DRUG | placebo | IV |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2009-12-01
- Completion
- 2009-12-01
- First posted
- 2008-05-06
- Last updated
- 2017-04-14
Locations
19 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00672074. Inclusion in this directory is not an endorsement.